Angela Hanson, MD, discusses relevant new Alzheimer disease therapies. Three learning objectives Dr. Hanson covers are understanding current data from amyloid vaccine trials, describing the mechanisms of potential therapies for behavorial symptoms, and to review recent recommendations from the Institute of Medicine.